The pharmaceutical industry faces many challenges in their quest to discover new medicines, including increasing costs, pricing pressures, and the increasing complexity of patient needs. Many pharma organizations have taken action to help their R&D teams better meet these challenges, becoming leaner, more collaborative and less insular in the process.

Here we examine the drivers behind these changes, the form those changes have taken to this point, and outline three key areas where these strategic changes can continue to evolve.